The opioid prodrug for acute pain will soon be available in both a stronger and weaker dose.

As 2018’s legislative trends continue to spill into 2019, what big initiatives might impact workers’ comp this year?

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

The American Gastroenterological Association released guidance on properly prescribing medications for OIC.

Five-to-ten times stronger than fentanyl, this drug is not for consumer use, and many claim it could worsen the opioid crisis.

Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

Healthesystems’ VP of Clinical Services offers insight into prescriptions in workers’ comp claims that should raise concerns.

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.